Monthly Archives: June 2018

Tilray Files for IPO

Tilray has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were mentioned in the filing, although the offering is valued up to $100 million, but this number is normally just a placeholder. The company intends to list its stock on the Nasdaq under the symbol TLRY.

The underwriters for the offering are....More>>>

Would You Lend $1 Trillion to a Bunch of 18-Year-Olds?

I (Porter) know a headline like that will leave me with only about five people still reading. So let me try again…   The next 18 months will likely see: a terrible bear market… a substantial economic recession… and a great opportunity for you to buy high-quality businesses at reasonable prices – but only if you raise cash now.   Don't believe me? Let me explain…....More>>>

Mark Cuban Just Spoke Out Against Trump’s Corporate Tax Cuts

Dallas Mavericks owner and billionaire entrepreneur Mark Cuban fully expressed his dissent for U.S. President Donald Trump’s tax code overhaul yesterday.

Specifically, he said that a cut in the U.S. corporate tax rate would have little to no effect on his investment decisions. In other words, he’s not confident that Trump’s tax cuts will change much.

We’ll....More>>>

Investors Dump Local Currency Emerging Market Bond Funds

Two exchange-traded funds tracking local currency bonds in emerging-markets absorbed massive block sales this week as global fears of trade disputes and rising U.S. Treasury yields sent developing nation debt into a tailspin.

Investors moved more than $73 million of the SPDR Bloomberg Barclays Emerging Markets Local Bond ETF, or EBND, on Thursday. That was the most since November 2012 and....More>>>

Tredje AP fonden Grows Position in Abbott Laboratories (ABT)

Tredje AP fonden increased its stake in Abbott Laboratories (NYSE:ABT) by 1.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 445,656 shares of the healthcare product maker’s stock after buying an additional 7,204 shares during the period. Abbott Laboratories accounts for....More>>>

The Hershey Company (HSY) Shares Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. raised its position in shares of The Hershey Company (NYSE:HSY) by 8.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,306 shares of the company’s stock after buying an additional 1,249 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in The....More>>>

How These 12 People Fit Mindfulness Into Their Work Day

&l;p&g;Mindfulness has numerous benefits, from lowering stress levels to helping with anxiety and depression to helping you regulate your emotions. And mindfulness can especially help at work, offering improved focus, better memory, the ability to stay calm under fire and better corporate citizenship, according to &l;a href=&q;https://hbr.org/2017/09/heres-what-mindfulness-is-and-isnt-good-for&q;....More>>>

Do stock-market investors really care about Gary Cohn and the Trump agenda?

Gary Cohn, the indispensable man?

Investors could be forgiven for thinking so after markets last week dipped in apparent reaction to unfounded rumors the former Goldman Sachs executive was set to leave his White House post in disgust over President Trumps reaction to deadly violence surrounding a white-supremacist rally in Charlottesville, Va.

The aftermath of Charlottesville saw a....More>>>

Coca-Cola: Five Reasons Not to Buy the Dip

Susquehanna’s Pablo Zuanic and Svetozar Stefanovic offer five reasons not to buy Coca-Cola (KO) following yesterday’s 4.8%earnings-induced drop:

Elise Amendola/Associated Press

We are cutting our price target to $39 (we now take a 5% peer premium). We have five concerns (including the valuation premium): comps get tougher so it is not clear how Coca-Cola meets 2016 sales....More>>>

Brokerages Anticipate Radware (RDWR) to Announce $0.08 EPS

Wall Street brokerages expect Radware (NASDAQ:RDWR) to report earnings per share (EPS) of $0.08 for the current quarter, according to Zacks. Four analysts have issued estimates for Radware’s earnings, with estimates ranging from $0.07 to $0.08. Radware reported earnings per share of $0.03 during the same quarter last year, which suggests a positive year-over-year growth rate of 166.7%. The....More>>>

Buy Capacite Infraprojects; target of Rs 397: Edelweiss

Edelweiss’s research report on Capacite Infraprojects

Capacite Infraprojects (Capacite) has etched a name for itself as a quality contractor in the buildings space since its inception in August 2012; today, it is working with almost all major real estate developers in the country. We believe it is in a sweet spot, due to: (1) RERA driven consolidation in the realty space; (2) improving....More>>>

Toy makers aim to capitalize on end of China’s one-child policy

Toy industry sees opportunity in China’s two-child policy Let’s call it the people’s problem of China. The country’s workforce has been shrinking since 2012 — the fallout from a decades-old policy that restricted most couples to only one child.

Faced with an aging population, labor shortages and slowing economic growth, China relaxed the law. Starting....More>>>

Wave Life Sciences: What’s Cooking Behind This Innovator?

Gene-based therapy is one of the next waves of therapeutic innovation to power this decade and far beyond. The FDA approvals regarding the RNA-based medicines of Sarepta Therapeutics (NASDAQ:SRPT) and the gene-therapy, Luxturna, of Spark Therapeutics (NASDAQ:ONCE) signaled the lowered regulatory hurdles. These milestones serve as the industry tailwinds to help superb drug innovators like....More>>>

PetIQ (PETQ) vs. Nu Skin Enterprises (NUS) Critical Review

Nu Skin Enterprises (NYSE: NUS) and PetIQ (NASDAQ:PETQ) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Analyst Ratings

Get Nu Skin Enterprises alerts:

This is a summary....More>>>

Living the Dream While Paying Off $83,000 in Student Loans

Katrina McGhee

Image Courtesy of Katrina McGhee

Have you ever found yourself in a place where you did all the right things to achieve success, only to realize youre not even sure you want the type of success youve earned? And then you feel stuck because you had to take on debt to get there?

This is an all-too-familiar story for student loan borrowers....More>>>